Anti-vegf antibodies
US7297334B2 · kind B2 · utility
62Cited by
4References
9Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 26, 2004 |
| Grant date | Nov 20, 2007 |
| Priority date | — |
| Expiry date | Oct 26, 2024 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/92
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Humanized and variant anti-VEGF antibodies and various uses therefor are disclosed. The anti-VEGF antibodies have strong binding affinities for VEGF; inhibit VEGF-induced proliferation of endothelial cells in vitro; and inhibit tumor growth in vivo.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.